RIO DE JANEIRO, BRAZIL - The Butantan Institute will forward the third phase of vaccine trials results to the agency on December 15th. This is the last stage before the immunizer is approved.
"It will be officially approved by ANVISA, I have no doubts about a vaccine that has already proven to be safe and effective in Europe and Asia and the results of 13,500 people, doctors and paramedics who have been tested here will be formally submitted on Tuesday, December 15th to ANVISA. I have absolute confidence that ANVISA will issue its opinion and authorize the Butantan vaccine, the . . .